MarketEthylestrenol
Company Profile

Ethylestrenol

Ethylestrenol, also known as ethyloestrenol or ethylnandrol and sold under the brand names Maxibolin and Orabolin among others, is an androgen and anabolic steroid (AAS) medication which has been used in the past for a variety of indications such as to promote weight gain and to treat anemia and osteoporosis but has been discontinued for use in humans. It is still available for veterinary use in Australia and New Zealand however. It is taken by mouth.

Medical uses
Ethylestrenol has been used for a variety of indications including: • As an adjunct for catabolic states such as corticosteroid therapy and convalescence as in chronic infections, extensive surgery, and severe trauma ==Contraindications==
Contraindications
Ethylestrenol should not be taken by pregnant women as it can masculinize female fetuses. ==Side effects==
Side effects
Side effects of ethylestrenol include virilization among others. ==Pharmacology==
Pharmacology
Pharmacodynamics (3-ketoethylestrenol), the active metabolite of ethylestrenol. As an AAS, ethylestrenol is an agonist of the androgen receptor (AR), similarly to androgens like testosterone and dihydrotestosterone (DHT). It has low estrogenic activity (via aromatization into ethylestradiol following transformation into norethandrolone), strong progestogenic activity, and a high ratio of anabolic to androgenic activity, similarly to other nandrolone derivatives. It is known to be metabolized into the closely related AAS norethandrolone (17α-ethyl-19-nortestosterone) in the body and has been regarded as a prodrug of norethandrolone. ==Chemistry==
Chemistry
Ethylestrenol, also known as 3-deketo-17α-ethyl-19-nortestosterone or as 17α-ethylestr-4-en-17β-ol, is a synthetic estrane steroid and a 17α-alkylated derivative of nandrolone (19-nortestosterone; 19-NT). It is specifically the 17α-ethyl and 3-deketo derivative of nandrolone as well as the 3-deketo derivative of norethandrolone (17α-ethyl-19-NT). Other related AAS include bolenol (3-deketo-17α-ethyl-19-nor-5-androstenediol), ethyldienolone (17α-ethyl-δ9-19-NT), norboletone (17α-ethyl-18-methyl-19-NT), propetandrol (17α-ethyl-19-NT 3β-propionate), and tetrahydrogestrinone (THG; 17α-ethyl-18-methyl-δ9,11-19-NT). The progestins allylestrenol (3-deketo-17α-allyl-19-NT) and lynestrenol (3-deketo-17α-ethynyl-19-NT) are also closely related to ethylestrenol, differing only by the C17α substitution. ==History==
History
Ethylestrenol was described in the literature in 1959 and approved for medical use in 1961 and in the United States in 1964. ==Society and culture==
Society and culture
Generic names Ethylestrenol is the generic name of the drug and its , , and , while éthylestrénol is its and ethylnandrol is its . The was formerly ethyloestrenol, but it was eventually changed. == References ==
tickerdossier.comtickerdossier.substack.com